跳至主要内容
临床试验/NCT01682551
NCT01682551Unknown2 期

Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2012年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
240
试验地点
1
主要终点
The incidence of AMS will be measured by the Lake Louise Self Report (Lake Louise Score ≥4 with headache)

研究概览

简要总结

This trial is aimed to evaluate the effects of "Wu Zhu Yu Tang" on the prevention of Acute Mountain Sickness(AMS).

详细描述

This study is a randomized, double blind, placebo-controlled clinical trial. It aims to demonstrate that (1) Chinese medicine prescription "Wu Zhu Yu Tang" can prevent Acute Mountain Sickness(AMS) (2) "Wu Zhu Yu Tang" can prevent AMS especially for Yang-Xu body constitution.

We will randomize 240 unacclimatized healthy adults. They will be randomized after stratification of the Yang-Xu score and the AMS history to receive Chinese medicine during one ascent and placebo during the other ascent. We will take them in Hehuan mountain for two days hike (24 hours) and an overnight over 3,000m. One month before the study, the subjects will fill the "Body Constitution Questionnaire BCQ" in order to evaluate their body constitution. Before, during and after the two days hike we will measure their blood pressure, heart rate and arterial oxygen saturation. The incidence of AMS will be measured by the Lake Louise Self Report (Lake Louise Score ≥4 with headache), we will also report the Lake Louise Clinical Assessment score and Lake Louise Functional Score.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults

排除标准

  • Chronic disease: cardiovascular disease, psychological disease, anemia, migraine.
  • long-term use of the following materials: Chinese herbs, steroid, antibiotics.
  • altitude acclimation: have been to mountain over 2000m in the past 1 month.
  • Pregnancy.

研究组 & 干预措施

Chinese Medicine

Experimental

The participators in this arm will take 2g (powder in capsule) of "Wu Zhu Yu Tang" or placebo orally three times in the first day and one time in the second day.

干预措施: Chinese Medicine (Drug)

Acetazolamide

Placebo Comparator

If the participators have the history of AMS, he/she will be randomized to take "Wu Zhu Yu Tang" plus "placebo of Acetalozamide" or "Acetalozamide" plus "placebo of Wu Zhu Yu Tang".

干预措施: Chinese Medicine (Drug)

Acetazolamide

Placebo Comparator

If the participators have the history of AMS, he/she will be randomized to take "Wu Zhu Yu Tang" plus "placebo of Acetalozamide" or "Acetalozamide" plus "placebo of Wu Zhu Yu Tang".

干预措施: Acetalozamide (Drug)

结局指标

主要结局

The incidence of AMS will be measured by the Lake Louise Self Report (Lake Louise Score ≥4 with headache)

时间窗: The Lake Louise Score will be measured in the noon of the second day after hiking to determine the onset of AMS.

The investigators will take the participators in Hehuan mountain for two days hike (24 hours) and an overnight over 3,000m. The Lake Louise score will measure before and after hiking.

次要结局

  • Blood pressure(Blood pressure will be measured before and after the hiking.)
  • Heart rate(Heart rate will be measured before and after the hiking.)
  • Arterial oxygen saturation(Arterial oxygen saturation will be measured before and after the hiking.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of the Prevention and Treatment Effects... | 临床试验